HSBC Holdings’s Sanara MedTech SMTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$301K Buy
17,283
+1,869
+12% +$38.5K ﹤0.01% 2452
2025
Q4
$365K Sell
15,414
-464
-3% -$12K ﹤0.01% 2436
2025
Q3
$497K Buy
15,878
+2,485
+19% +$75K ﹤0.01% 2107
2025
Q2
$382K Buy
+13,393
New +$402K ﹤0.01% 2303

Other funds holding SMTI

HSBC Holdings's SMTI Position: Q1 2026 in Review

HSBC Holdings increased its Sanara MedTech (SMTI) stake by 12% in Q1 2026, buying an estimated $38.5K and bringing the position to 17,283 shares worth $301K. The position accounts for ﹤0.01% of the portfolio, ranked #2452.

HSBC Holdings first reported a position in SMTI in Q2 2025 and has held it in 4 quarters since. The position peaked at $497K in Q3 2025. 65 funds tracked by Wall St. Rank hold SMTI as of Q1 2026.

  • HSBC Holdings held 17,283 shares of Sanara MedTech worth $301K as of Q1 2026.
  • HSBC Holdings bought 1,869 Sanara MedTech shares in Q1 2026, an estimated $38.5K.
  • Sanara MedTech made up ﹤0.01% of HSBC Holdings's portfolio in Q1 2026, its #2452 holding.
  • HSBC Holdings first reported a position in Sanara MedTech in Q2 2025 and has held it in 4 quarters since.
  • HSBC Holdings's Sanara MedTech position peaked at $497K in Q3 2025.
  • 65 funds tracked by Wall St. Rank held Sanara MedTech as of Q1 2026.

Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.